Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
Pure Autonomic Failure; Autoimmune Encephalitis; orthostatic hypotension; head pain; This is a spontaneous report received from a Consumer or other non HCP. A 20-year-old female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown (booster) single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization completed, Unknown manufacturer), for Covid-19 immunization. The following information was reported: AUTONOMIC FAILURE SYNDROME (disability, medically significant), outcome "not recovered", described as "Pure Autonomic Failure"; ENCEPHALITIS AUTOIMMUNE (disability, medically significant), outcome "not recovered", described as "Autoimmune Encephalitis"; ORTHOSTATIC HYPOTENSION (disability), outcome "not recovered"; HEADACHE (disability), outcome "not recovered", described as "head pain". Event information: It was reported that the patient has been diagnosed with Pure Autonomic Failure and Autoimmune Encephalitis. She has chronic, daily head pain, orthostatic hypotension also a list of other symptoms. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.